Since developmental nicotine exposure has been shown to disrupt dopaminergic signaling in brain regions associated with mood and anxiety control (Jobson et al., 2019), we decided to investigate changes in D1R and D2R expression following chronic nicotine exposure (Figure 5A). The gene discussed is DRD2; the disease is Anxiety.